Seeing Is Believing
Currently out of the existing stock ratings of Andrew Berens, 154 are a BUY (68.75%), 49 are a HOLD (21.88%), 21 are a SELL (9.38%).
Analyst Andrew Berens works with a stock forecast success ratio of 51.47% fulfilled within 182.42 days on average. Previously, Andrew Berens worked at LEERINK.
Andrew Berens’s has documented 433 price targets and ratings displayed on 38 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on BPMC, Blueprint Medicines Corp at 06-May-2024.
Analyst best performing recommendations are on ELEV (ELEVATION ONCOLOGY).
The best stock recommendation documented was for ELEV (ELEVATION ONCOLOGY) at 1/9/2023. The price target of $1 was fulfilled within 3 days with a profit of $0.2 (25%) receiving and performance score of 83.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
33
$0.2 (0.61%)
28
5 days ago
7/7 (100%)
$-1.54 (-4.46%)
165
Hold
30
$-2.8 (-8.54%)
32
2 months 15 days ago
3/3 (100%)
$-2.99 (-9.06%)
224
Buy
42
$9.2 (28.05%)
67
10 months 11 days ago
5/12 (41.67%)
$13.87 (49.31%)
213
Buy
38
$5.2 (15.85%)
40
10 months 11 days ago
0/4 (0%)
$9.87 (35.09%)
Buy
37
$4.2 (12.80%)
33
1 years 9 months 3 days ago
6/11 (54.55%)
$7.26 (24.41%)
69
Which stock is Andrew Berens is most bullish on?
Which stock is Andrew Berens is most reserved on?
What Year was the first public recommendation made by Andrew Berens?